04/28/2026
Big movement in the peptide space 👇
The FDA is currently evaluating and reclassifying certain peptides that were previously placed on the Category 2 list.
What we’re seeing:
• Some peptides may be removed from the restricted category
• Increased awareness and review around peptide use
• Ongoing evaluation… nothing finalized yet
Our take:
We’ve been prescribing peptides since 2019 and this isn’t new for us.
We don’t follow trends… we follow what works, what’s safe, and what’s backed by the right partnerships and oversight.
As things continue to evolve, we’ll keep you informed with real, accurate updates—not hype.
Stay tuned for more đź‘€